Angiotech Pharmaceuticals, Inc. (Angiotech) announced the launch of a series of new, proprietary Quill SRS product codes specifically designed for laparoscopic, or minimally invasive, gynecology procedures, including hysterectomies and myomectomies.
Angiotech’s new Quill SRS product codes for laparoscopic gynecology procedures are available in our polydioxanone (PDO) suture material in size -0- with 7 cm by 7 cm and 14 cm by 14 cm lengths, and include our newly designed 36 mm needles.
Angiotech discovers, develops and markets treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury.